Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema
Ranibizumab treatment was associated with a significant reduction in CRVE and increase in AVR. It is possible that the positive effect of ranibizumab therapy on improvements in BCVA and CMT may be related to reduction of retinal venous calibre and hydrostatic pressure.
Authors
- Noha Ali
- Sanjeewa Wickremasinghe (ORCID: https://orcid.org/0000-0002-0752-5876)
- Luke K. Chehade (ORCID: https://orcid.org/0000-0001-7744-6535)
- Lyndell L. Lim (ORCID: https://orcid.org/0000-0003-2491-685X)
- Paul G. Sanfilippo (ORCID: https://orcid.org/0000-0002-1778-9154)
- Sukhpal S. Sandhu
Institutions
- The University of Melbourne (AU)
- The Royal Victorian Eye & Ear Hospital (AU)
- Centre for Eye Research Australia (AU)
- Melbourne Clinic (AU)
- The University of Adelaide (AU)
- Assiut University (EG)
Publication Details
- Journal
- Journal of Ophthalmology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/joph/5637071
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- State Government of Victoria
- Novartis Pharma
- Medical Research Council
- National Health and Medical Research Council